IL18 and myocardial infarction: Colchicine blocks the assembly of the NLRP3 inflammasome, thereby reducing its activation and the release of proinflammatory cytokines such as interleukin-1β (IL-1β) and IL-18, key molecules in amplifying the inflammatory response after myocardial infarction.